Theravance Biopharma buy quelbe60
Start price
28.02.26
/
50%
€15.20
Target price
28.02.27
-
Performance (%)
-20.39%
End price
10.03.26
€12.10
Summary
This prediction ended on 10.03.26 with a price of €12.10. The price of Theravance Biopharma has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -20.39%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Theravance Biopharma | 0.000% | 0.000% |
| iShares Core DAX® | 0,85 % | 0,39 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % |
| iShares S&P 500 | 0,06 % | 0,78 % |
According to quelbe60 what are the pros and cons of Theravance Biopharma for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by quelbe60 for this prediction
In the thread Theravance Biopharma diskutieren
Buy Theravance Biopharma